NCT07193485 Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction
| NCT ID | NCT07193485 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Eustachian Tube Dysfunction |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-05-12 |
| Primary Completion | 2025-10-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-05-12 with a primary completion date of 2025-10-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Eustachian tube dysfunction is distressing probelm. drugs usually are not effective. compelemtary tehrapies like Buteyko breathing may be effective
Eligibility Criteria
Inclusion Criteria: * Eustachian Tube Dysfunction (chronic obstructive form) * unilateral ear affetion * senior patients * chronci affection more than 3 months Exclusion Criteria: * obesity * cardiac probelms repsiratory problems
Contact & Investigator
Ali MA Ismail, lecturer
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT07193485 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 75 Years, studying Eustachian Tube Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07193485 currently recruiting?
Yes, NCT07193485 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT07193485 trial being conducted?
This trial is being conducted at Dokki, Egypt.
Who is sponsoring the NCT07193485 clinical trial?
NCT07193485 is sponsored by Cairo University. The principal investigator is Ali MA Ismail, lecturer at Cairo University. The trial plans to enroll 40 participants.